GNLX- Genelux Corporation

Name: Genelux Corporation Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Genelux Corporation (GNLX) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 18 sells. GNLX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Zindrick Thomas	534.8K	$1.66M	-
Dir	Thomas John	492.8K	$1.53M	-
Other	Litten Jason	275.0K	$855.3K	-
Other	Groen Eric	270.0K	$839.7K	-
Other	Cappello Joseph	155.2K	$482.5K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 25, 2026	Smalling Ralph54	Head Of Regulatory	Sell	585	$2.46	$1,437.30	-0.4%	-	-
Mar 24, 2026	Zindrick Thomas45	President And CEO	Sell	3,582	$2.42	$8,668.44	-0.7%	-	-
Mar 24, 2026	Cappello Joseph51	Chief Technical Officer	Sell	906	$2.42	$2,192.52	-0.6%	-	-
Mar 24, 2026	Yu Yong80	SVP, Clinical Development	Sell	906	$2.42	$2,192.52	-0.6%	-	-
Dec 5, 2025	Smalling Ralph54	Head Of Regulatory	Sell	2,332	$3.75	$8,740.38	-0.8%	-42.1%	-
Dec 1, 2025	Thomas John77	Director	Sell	10,000	$5.00	$50,008.00	-2.0%	-41.2%	-
Nov 17, 2025	Cappello Joseph51	Chief Technical Officer	Sell	3,706	$3.88	$14,361.21	-0.8%	-51.2%	-
Nov 17, 2025	Yu Yong80	SVP, Clinical Development	Sell	4,192	$3.82	$16,031.90	-1.4%	-51.2%	-
Nov 17, 2025	Zindrick Thomas45	President And CEO	Sell	17,182	$3.86	$66,369.89	-1.6%	-51.2%	-
May 12, 2025	Zindrick Thomas45	President And CEO	Sell	10,764	$2.92	$31,430.88	-5.3%	+18.0%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC